Conference abstractPublished 30 Nov 2022
Efficacy of a Multi-ingredient Coriolus Versicolor-Based Vaginal Gel in High-Risk HPV Infected Patients: Results of 6 Different Studies
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objectives: To evaluate the consistency of the efficacy of a multi-ingredient Coriolus versicolor-based vaginal gel, Papilocare®, on High-Risk Human Papillomavirus (HR-HPV) clearance in 6 different studies1. Methods: Results from 4 independent observational studies (6 month-treatment period with Papilocare®) were compared to results from a randomized, open, parallel, controlled trial (Paloma: NCT04002154)2 and an observational, multicenter, prospective, one-cohort study (PapilOBS: NCT04199260)3. • Vigo study: Prospective one-cohort (POC). Secondary endpoint (SE), HPV clearance in 86 patients infected by HPV 16 and/or 18. • Coruña study: Retrospective one-cohort (ROC). Primary endpoint (PE), HPV clearance assessed in 86 medical patients’ records. • Hospitalet study: ROC. PE, Composite efficacy variable (patients with normal cytology and/or HPV clearance) in 91 HRHPV patients. • Roma study4: Retrospective controlled. PE, HR-HPV clearance in 183 patients. • Paloma trial: RCT, SE, HR-HPV clearance in 91 patients. • PapilOBS study: POC, SE, HR-HPV clearance in 192 patients. Results: 48% of patients cleared 16/18HPV in Vigo study. 58% of reduction was observed in the number of HR-HPV patients (Coruña) and 72.5% normalized cytology and/or cleared HR-HPV (Hospitalet). 67% HR-HPV clearance was observed (treated group) vs 37.2% (control group), in the Roma study. In the Paloma trial, HR-HPV clearance reached 63% (treated group) vs 40% (control group). 57.4% HR-HPV clearance was observed in the PapilOBS study. Conclusions: Papilocare® has shown significant consistent rates of efficacy with a 64% of HR-HPV clearance in weighted average in 6 different studies involving more than 700 patients. These data reinforce the beneficial effect in HR-HPV patients.Recent Publications 1. Serrano, Luis et al. “Efficacy of a Coriolus versicolor-Based Vaginal Gel in Women With Human Papillomavirus-Dependent Cervical Lesions: The PALOMA Study.” Journal of lower genital tract disease vol. 25,2 (2021): 130-136. 2. Gaslain Y, et al. 698 Real-life efficacy of a multi-ingredient Coriolus versicolor based vaginal gel in high-risk HPV patients: the PAPILOBS study final results. International Journal of Gynecologic Cancer 2021;31:A314. 3. Criscuolo, Anna Angela et al. “Therapeutic Efficacy of a Coriolus versicolor-Based Vaginal Gel in Women with Cervical Uterine High-Risk HPV Infection: A Retrospective Observational Study.” Advances in therapy vol. 38,2 (2021): 1202-1211. PDF HTML Digital File
Keywords
Subjects
Nursing & HealthcareAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nursing Research and Practice
- SubjectNursing & Healthcare
- BylineArticles whose byline prints “Cortes J”
- BylineArticles whose byline prints “Dexeus D”
- BylineArticles whose byline prints “Palacios S”
- BylineArticles whose byline prints “Serrano L”
- BylineArticles whose byline prints “Gajino C”
- BylineArticles whose byline prints “Marin E”
- BylineArticles whose byline prints “Criscuolo A”
- BylineArticles whose byline prints “Riera M”
